Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAGLP-1s may prevent adverse outcomes in patients with peripheral artery disease and diabetes, according to data published in the Journal of the American Heart Association.Researchers reported that GLP-1 receptor agonist use among patients with PAD and diabetes was associated with lower risk for mortality, hospitalization, revascularization and amputation compared with those prescribed metformin.“Obesity and PAD, including chronic limb-threatening ischemia, are linked to increased inflammation, poor blood vessel function, insulin resistance, oxidative stress and faster hardening of the
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | GLP-1s may lower risk for death, heart events among people with hidradenitis suppurativa | 5 | 7 | 08-07-2026 |
| 2 | Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity | 7 | 8 | 31-07-2025 |
| 3 | SGLT2 and GLP-1 medications unlock new potential in CKM care | 2 | 6 | 09-07-2026 |
| 4 | Most websites prescribe GLP-1s without clinician visit | 0 | 7 | 09-07-2026 |
| 5 | Will GLP-1s lead to fewer prescriptions for older adults? | 0 | 7 | 25-06-2026 |
| 6 | Ученые выявили новый побочный эффект приема "Оземпика" | 0 | 7 | 30-06-2026 |
| 7 | Weight Loss at a Cost—Sense and Sensibility | 0 | 7 | 25-06-2026 |
| 8 | Women more often hired after losing weight on GLP-1s: Study | 0.2 | 0.6 | 03-07-2026 |
| 9 | Wegovy pills 'are just as good as fat jabs when it comes to weight loss - but injections are better for your heart' | 0 | 5 | 09-07-2026 |
| 10 | Therapies to lower BP, lipids close gap in obesity-related CVD | 0 | 7 | 06-07-2026 |